Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Cortex Pharmaceuticals

Cortex Pharmaceuticals Incorporated is a development stage enterprise that was organized in 1987 to engage in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurodegenerative diseases and other neurological and psychiatric disorders. Since 1993, the primary effort at Cortex has been centered on developing products that affect the AMPA-type glutamate receptor, a complex of proteins that is involved in most "excitatory" communication between nerve cells in the human brain. Cortex is developing a family of chemical compounds, knownas Ampakines/(R)/, that enhance the activity of this receptor. Cortex believes that Ampakines hold promise for correcting deficits brought on by a variety of diseases and disorders that are known, or thought, to involve depressed functioning of pathways in the brain that use glutamate as a neurotransmitter.


Contact Details:
15231 Barranca Parkway
Irvine
CA
92618
United States of America
Tel:714 727 3157
Fax:714 727 3657
Email:info@cortexpharm.com
WWW:

www.cortexpharm.com/




Loading...

Recent Publications by Cortex Pharmaceuticals:

Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report.
This progress report briefly describes the rationale and study design for...
29th January, 2003
Cortex Pharmaceuticals, Inc., Irvine, CA 92618, USA. J Mol Neurosci. 2002 Aug-Oct;19(1-2):197-200.
Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein.
A critical issue concerning Alzheimer's disease is its selectivity, which...
20th June, 2000
Cortex Pharmaceuticals, Inc., Irvine, California 92618, USA. J Comp Neurol. 1998 Jul 20;397(1):139-47.

Press Releases on Cortex Pharmaceuticals:

BioPortfolio Logo
Medivation Names Hank Mansbach, M.D., Vice President of Medical Affairs 23rd October, 2009 Medivation, Inc.
SAN FRANCISCO, Oct. 23 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced the appointment of Hank Mansbach, M.D., as vice president of medical affairs. Dr. Mansbach will lead

BioNews Results for Cortex Pharmaceuticals:

Cortex Pharmaceuticals Inc. (COR) Corporate Event Announcement No...
Zibb:  Nov 4 2009 3:55AM Matching: cortex pharmaceuticals
Cortex Pharmaceuticals Inc-Detailed Product Pipeline - research report released
PR inside:  Nov 3 2009 8:11AM Matching: cortex pharmaceuticals
Life Sciences: Research results from University of Paris update knowledge of life sciences
NewsRX:  Nov 3 2009 5:10AM Matching: cortex pharmaceuticals
Life Sciences: Scientists at University of Queensland target life sciences
NewsRX:  Nov 1 2009 4:31AM Matching: cortex pharmaceuticals
Cortex Pharmaceuticals Inc-Financial Company Report - research report released
PR inside:  Oct 30 2009 5:34PM Matching: cortex pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Cortex Pharmaceuticals news.

Cortex Pharmaceuticals Clinical Trials:

Effects of CX516 on Functioning in Fragile X Syndrome and Autism

Cortex Pharmaceuticals Patents:

US Patent No.Title
6166008 Treatment of schizophrenia with ampakines and neuroleptics
5985871 Benzoxazine compounds for enhancing synaptic response
5736543 Benzoxazines for enhancing synaptic response
5650409 Benzoyl piperidines/pyrrolidines for enhancing synaptic response
5622981 Use of metabotropic receptor agonists in progressive neurodegenerative diseases

View more Cortex Pharmaceuticals patents.

Cortex Pharmaceuticals (COR) Financial information Links from Barchart

COR Quote from from Barchart.com
COR Chart from from Barchart.com
COR Profile from from Barchart.com
COR Opinion from from Barchart.com

View more Cortex Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 385 times since April 2007, the link to the organisation's website has been followed 55 times

Recent Search Terms used to find this page: last news cortex pharma 2009 | .

Search for more companies in Irvine

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Cortex Pharmaceuticals

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.